| Name | Rotech |
|---|---|
| Organization Name | Oxygen Therapy Associates Inc |
| Location | 1209 E South 11th St, Abilene, Texas 79602 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (325) 692-7059 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Asterias Biotherapeutics, Inc. today announced the successful completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration for AST-VAC1, its investigational therapy targeting acute myeloid leukemia (AML).
A new Phase I clinical trial sponsored by the Vermont Cancer Center at the University of Vermont and Fletcher Allen Health Care has opened to test the investigational drug DFMO, or alpha-difluoromethylornithine, as a treatment for the pediatric cancer neuroblastoma.
A study has found that Medicare spending on drugs varies significantly in different regions, and that increased drug spending isn't offset by lower spending on hospital care, doctors visits and other health services, HealthDay/Bloomberg Businessweek reports.
With over 3.25 million people infected, healthcare systems of even the most developed nations are overwhelmed. Cancer patients and survivors, for example, are particularly vulnerable during this epidemic and not only because of their increased vulnerable immunocompromised state, which makes them prone to the infection. They are also at risk of missing out on essential cancer care due to the unavailability of resources.
To help determine if the descendants of Gulf War and post-9/11 veterans are at risk for health effects resulting from the service members' exposure to toxicants during deployment, a new report from the National Academies of Sciences, Engineering, and Medicine recommends the creation of a health monitoring and research program.
› Verified 4 days ago
| NPI Number | 1275592289 |
| Organization Name | OXYGEN THERAPY ASSOCIATES INC |
| Doing Business As | ROTECH |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1209 E South 11th St, Abilene, TX 79602 |
| Phone Number | 325-692-7059 |
News Archive
Asterias Biotherapeutics, Inc. today announced the successful completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration for AST-VAC1, its investigational therapy targeting acute myeloid leukemia (AML).
A new Phase I clinical trial sponsored by the Vermont Cancer Center at the University of Vermont and Fletcher Allen Health Care has opened to test the investigational drug DFMO, or alpha-difluoromethylornithine, as a treatment for the pediatric cancer neuroblastoma.
A study has found that Medicare spending on drugs varies significantly in different regions, and that increased drug spending isn't offset by lower spending on hospital care, doctors visits and other health services, HealthDay/Bloomberg Businessweek reports.
With over 3.25 million people infected, healthcare systems of even the most developed nations are overwhelmed. Cancer patients and survivors, for example, are particularly vulnerable during this epidemic and not only because of their increased vulnerable immunocompromised state, which makes them prone to the infection. They are also at risk of missing out on essential cancer care due to the unavailability of resources.
To help determine if the descendants of Gulf War and post-9/11 veterans are at risk for health effects resulting from the service members' exposure to toxicants during deployment, a new report from the National Academies of Sciences, Engineering, and Medicine recommends the creation of a health monitoring and research program.
› Verified 4 days ago
News Archive
Asterias Biotherapeutics, Inc. today announced the successful completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration for AST-VAC1, its investigational therapy targeting acute myeloid leukemia (AML).
A new Phase I clinical trial sponsored by the Vermont Cancer Center at the University of Vermont and Fletcher Allen Health Care has opened to test the investigational drug DFMO, or alpha-difluoromethylornithine, as a treatment for the pediatric cancer neuroblastoma.
A study has found that Medicare spending on drugs varies significantly in different regions, and that increased drug spending isn't offset by lower spending on hospital care, doctors visits and other health services, HealthDay/Bloomberg Businessweek reports.
With over 3.25 million people infected, healthcare systems of even the most developed nations are overwhelmed. Cancer patients and survivors, for example, are particularly vulnerable during this epidemic and not only because of their increased vulnerable immunocompromised state, which makes them prone to the infection. They are also at risk of missing out on essential cancer care due to the unavailability of resources.
To help determine if the descendants of Gulf War and post-9/11 veterans are at risk for health effects resulting from the service members' exposure to toxicants during deployment, a new report from the National Academies of Sciences, Engineering, and Medicine recommends the creation of a health monitoring and research program.
› Verified 4 days ago
Choice Medical Supply Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 17 Windmill Cir, Abilene, Texas 79606 Phone: (325) 677-2250 | |
Cvs Pharmacy #07443 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 965 N Judge Ely Blvd, Abilene, Texas 79601 Phone: (325) 677-0616 | |
Cvs Pharmacy #07271 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4580 Buffalo Gap Rd, Abilene, Texas 79606 Phone: (325) 698-0651 | |
Hendrick Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1318 N 8th St, Abilene, Texas 79601 Phone: (325) 673-3711 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1209 E South 11th St, Abilene, Texas 79602 Phone: (325) 692-7059 |